Ceftobiprole

Revision as of 19:09, 4 April 2015 by Gerald Chi (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:Chembox new

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Ceftobiprole is an experimental cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus.[1] It was discovered by Basilea Pharmaceutica and is being developed by Johnson & Johnson Pharmaceutical Research and Development.[2]

References

  1. ↑ Yun HC, Ellis MW, Jorgensen JH (2007). "Activity of ceftobiprole against community-associated methicillin-resistant Staphylococcus aureus isolates recently recovered from US military trainees". doi:10.1016/j.diagmicrobio.2007.06.023. PMID 17911001.
  2. ↑ Basilea.com
Retrieved from "https://www.wikidoc.org/index.php?title=Ceftobiprole&oldid=1082649"